JPS6479119A - Drug of blended two components - Google Patents

Drug of blended two components

Info

Publication number
JPS6479119A
JPS6479119A JP23776487A JP23776487A JPS6479119A JP S6479119 A JPS6479119 A JP S6479119A JP 23776487 A JP23776487 A JP 23776487A JP 23776487 A JP23776487 A JP 23776487A JP S6479119 A JPS6479119 A JP S6479119A
Authority
JP
Japan
Prior art keywords
soysterol
blended
drug
improving effect
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP23776487A
Other languages
Japanese (ja)
Other versions
JPH0480007B2 (en
Inventor
Yoshiaki Nakai
Munehiro Tomikawa
Naoki Imoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP23776487A priority Critical patent/JPS6479119A/en
Publication of JPS6479119A publication Critical patent/JPS6479119A/en
Publication of JPH0480007B2 publication Critical patent/JPH0480007B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain a drug of blended two components showing more improved lowering action on serum cholesterol, improving effect on serum lipid and improving effect on arteriosclerosis compared with separative use of each component, having high safety, by blending pantethine with soysterol. CONSTITUTION:A drug of blended two components obtained by blending pantethine with soysterol as active ingredients. Soysterol is an unsaponified substance of soybean oil, contains vegetable sterol and natural tocopherol in high concentration and various kinds of soysterols occur depending upon the contents of the components thereof. A soysterol prescribed by the drug component standard not included in Japanese Pharmacopoeia is generally preferable among the soysterols. The weight ratio of the active ingredients blended is usually 1:0.5-5.0, preferably about 1:2. Addition of vitamin E (e.g. alpha.tocopherols) is further expected to have improving effect on hyperlipemia and improving effect on arteriosclerosis.
JP23776487A 1987-09-22 1987-09-22 Drug of blended two components Granted JPS6479119A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23776487A JPS6479119A (en) 1987-09-22 1987-09-22 Drug of blended two components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23776487A JPS6479119A (en) 1987-09-22 1987-09-22 Drug of blended two components

Publications (2)

Publication Number Publication Date
JPS6479119A true JPS6479119A (en) 1989-03-24
JPH0480007B2 JPH0480007B2 (en) 1992-12-17

Family

ID=17020100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23776487A Granted JPS6479119A (en) 1987-09-22 1987-09-22 Drug of blended two components

Country Status (1)

Country Link
JP (1) JPS6479119A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1148062A3 (en) * 1994-09-29 2003-06-11 The University of British Columbia Sterol compositions from pulping soap
WO2004028523A1 (en) * 2002-09-30 2004-04-08 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
JP2006016356A (en) * 2004-07-02 2006-01-19 Dai Ichi Seiyaku Co Ltd Composition for hypercholesterolemia

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1148062A3 (en) * 1994-09-29 2003-06-11 The University of British Columbia Sterol compositions from pulping soap
EP1707572A3 (en) * 1994-09-29 2012-06-20 University Of British Columbia Sterol compositions from pulping soap
WO2004028523A1 (en) * 2002-09-30 2004-04-08 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
CN100362987C (en) * 2002-09-30 2008-01-23 第一制药株式会社 Particulate product comprising pantethine
US7709028B2 (en) 2002-09-30 2010-05-04 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
JP2006016356A (en) * 2004-07-02 2006-01-19 Dai Ichi Seiyaku Co Ltd Composition for hypercholesterolemia

Also Published As

Publication number Publication date
JPH0480007B2 (en) 1992-12-17

Similar Documents

Publication Publication Date Title
Meydani et al. Protective effect of vitamin E on exercise-induced oxidative damage in young and older adults
Haskell et al. Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects
CL2008002802A1 (en) Fat blend comprising a liquid oil component and a texturizing agent; food product containing the mixture; procedure to reduce the amount of hard concentrate base in the mix; and use of sterol fatty acid esters, stanol or their mixtures as texturizing agent. (divisional sol. 846-98).
EA199800779A1 (en) COMPOSITION BASED ON SOY, USED AS A FOOD SUPPLEMENT OR TO REDUCE THE CONTENT OF LIPID IN THE BLOOD SERUM
YU46978B (en) PROCEDURE FOR OBTAINING PREPARATIONS FOR NOSAL USE
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
CO4410285A1 (en) CHEMICALLY CO-INTERESTERIFIED FAT COMPOSITIONS RANDOM FOR USE IN CHILDREN'S MILK FORMULAS
JPS56135416A (en) Pharmaceutical preparation for skin
KR840005339A (en) Method for preparing an aqueous solution containing a fat soluble substance
KR900701174A (en) Phospholipid-containing compositions, methods for their preparation and use as excipients for pharmaceutical substances
ATE146656T1 (en) EDIBLE FATS AND OILS STABILIZED WITH SESAME OIL AS AN INGREDIENTS
DE60027142T2 (en) Self-emulsifying system for drug delivery of fat-soluble drugs
PH25286A (en) Sustained release drug preparation
DE60019239D1 (en) Fat soluble vitamins containing compositions
KR950700725A (en) Liposomal composition (LIPOSOME COMPOSITION)
JPS6479119A (en) Drug of blended two components
JPS5569688A (en) Antioxidant
DK467380A (en) PROCEDURE FOR THE PREPARATION OF A DIETARY MEDICINE
Ney et al. Relative effects of dietary oleic-and linoleic-rich oils on plasma lipoprotein composition in rats
GR3020289T3 (en) Drug for the treatment of agitation state and nerve dysfonction
KR900001370A (en) Ibudillast lipid microspheres and preparation method thereof
JPH01143826A (en) Fat emulsion of fine particle
ATE35620T1 (en) PHARMACEUTICAL PREPARATION WITH RETARDED EFFECT.
JPS6471439A (en) Freshness retaining agent for fishes and shellfishes
KR940021037A (en) Cosmetic composition containing liposome powder

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071217

Year of fee payment: 15